tiprankstipranks
Trending News
More News >
Torii Pharmaceutical Co Ltd (JP:4551)
:4551
Japanese Market

Torii Pharmaceutical Co (4551) Income Statement

Compare
0 Followers

Torii Pharmaceutical Co Income Statement

Last quarter (Q4 2024), Torii Pharmaceutical Co's total revenue was ¥17.09B, an increase of 10.23% from the same quarter last year. In Q4, Torii Pharmaceutical Co's net income was ¥1.52B. See Torii Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 60.43B¥ 54.64B¥ 48.89B¥ 46.99B¥ 41.70B
Gross Profit
¥ 24.42B¥ 24.79B¥ 23.38B¥ 24.34B¥ 21.74B
Operating Expenses
¥ 17.62B¥ 19.76B¥ 17.84B¥ 19.68B¥ 17.00B
Depreciation and Amortization
¥ 408.00M¥ 459.00M¥ 252.00M¥ 279.00M¥ 461.00M
EBITDA
¥ 7.21B¥ 5.83B¥ 5.97B¥ 5.05B¥ 4.69B
Operating Income
¥ 6.80B¥ 5.04B¥ 5.54B¥ 4.66B¥ 4.74B
Other Income/Expenses
¥ -73.00M¥ 557.00M¥ 182.00M¥ 111.00M¥ -513.00M
Pretax Income
¥ 6.72B¥ 5.59B¥ 5.72B¥ 4.77B¥ 4.22B
Net Income
¥ 5.04B¥ 4.12B¥ 3.94B¥ 3.37B¥ 3.50B
Per Share Metrics
Basic EPS
¥ 179.37¥ 146.57¥ 140.38¥ 120.11¥ 124.47
Diluted EPS
¥ 179.37¥ 146.57¥ 140.38¥ 120.11¥ 124.46
Weighted Average Shares Outstanding
28.11M 28.10M 28.10M 28.09M 28.08M
Weighted Average Shares Outstanding (Diluted)
28.11M 28.10M 28.10M 28.09M 28.08M
Currency in JPY

Torii Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis